VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
56 hedge funds and large institutions have $17.8M invested in Viracta Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
66% less capital invested
Capital invested by funds: $52.8M → $17.8M (-$35M)
Holders
56
Holding in Top 10
1
Calls
$65K
Puts
$6K
Top Buyers
| 1 | +$491K | |
| 2 | +$139K | |
| 3 | +$87.3K | |
| 4 |
Millennium Management
New York
|
+$70.8K |
| 5 |
Renaissance Technologies
New York
|
+$64K |
Top Sellers
| 1 | -$502K | |
| 2 | -$313K | |
| 3 | -$308K | |
| 4 |
E
Ergoteles
New York
|
-$165K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$127K |